• Greenkraft is the only company to manufacture both CNG- and LPG-powered trucks
• Among few companies in the world to offer a refrigeration option for alternative fuel trucks
• Company has experienced a significant uptick in orders from fleet operators during 2017

Aiming to become the leading provider of alternative fuel trucks in North America, Greenkraft, Inc. (OTCQB: GKIT) is at the head of its class in introducing alternative fuel products that are both cost-effective and of the highest quality. The company was founded in 2008 with the objective of manufacturing alternative commercial forward cab trucks and alternative fuel systems for a variety of vehicles. Greenkraft’s commercial trucks operate under the power of alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

The way is clear for Greenkraft to become number one in its field, as the company controls almost of all of the market share in the clean energy truck market. Greenkraft is currently the only manufacturer to offer trucks that are powered by both CNG and LPG, and electric vehicles are also forthcoming, according to the company’s website.

Greenkraft’s products include commercial trucks, alternative fuel systems and eco-friendly engines, all of which are environmentally friendly automotive solutions. The company’s products boast price advantages, American craftsmanship, enviro-friendliness and exceptional efficiency.

Greenkraft’s commercial trucks feature a cab forward design that enables the passenger area to be considerably larger than one finds in other similarly-sized vehicles. Several options are also offered regarding tank capacity, letting customers choose the most efficient model for their needs. Greenkraft is additionally one of the only companies on Earth that offers an alternative fuel truck with a refrigeration option.

Demand for Greenkraft’s trucks has greatly increased this year as orders have poured in from fleet operators throughout the United States. The various government incentives offered for companies that change over to alternative-fuel trucks have helped fuel this surge. Many of the fleet operators interested in Greenkraft’s pioneering trucks also operate their own filling stations, through which they are able to get CNG at low prices.

During 2017, Greenkraft has been executing a clear-cut growth plan, which has included the expansion of the company’s factory as well as the introduction of a new line of trucks—the G3 and G4—which will accommodate respective weights of 26,000 and 33,000 pounds.

For more information, visit the company’s website at www.GreenkraftInc.com

Let us hear your thoughts: Greenkraft, Inc. Message Board

• Wholly owned zinc project has estimate of 3.7 million tons of indicated resources and 4.09 million tons of inferred resources
• 525 acres of mineral rights includes zinc with significant assets of copper, silver and gold
• Advanced-stage project led by experienced management team with key technical advisors
• Global shortfall in zinc production equals significant opportunity

Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF), a mineral exploration company, is focused on developing its advanced-stage, wholly owned Blue Moon zinc project in central California. The project sits within Mariposa County, an area of active mines and exploration projects since it was part of the California gold rush era. Blue Moon’s 525 acres of mineral rights are assigned to patented and unpatented claims accessible by a gravel road off a nearby highway with main utility lines nearby.

The Blue Moon deposit is one of many located in the Foothills Massive Sulphide Belt in the Sierra Nevada Mountains of California. The property has a long history of exploration and saw small-scale mining during World War II. The current project, to be mined by underground methods, contains an estimated 3.70 million tons with a grade of 8.33% zinc equivalent for approximately 377 million pounds of zinc in the indicated category and another 4.09 million tons with a grade of 7.84% zinc equivalence for approximately 395 pounds of zinc in the inferred category. Significant bi-products of copper, silver and gold are also indicated. The deposit is open at depth and along strike with a high likelihood of expansion.

Current spot prices for zinc is approximately $1.40 per pound, which increases the potential returns of the Blue Moon project.

The historical database shows extensive plans to put the Blue Moon project into production, including several scoping and optimization studies. Past environmental work performed, along with an historical permit and reclamation plan approved for certain underground development, highlights past local county support for the project. These historical studies and permits are expected to help fast track the project’s progress as they form an excellent base for the upcoming Preliminary Economic Assessment and later feasibility study.

Among the significant historical studies conducted is a 1998 metallurgical report that shows recovery rates of 95 percent for zinc and lead, 93 percent for copper, 65 percent for silver and 70 percent for gold (http://dtn.fm/F3AhW). The report indicates that simple processing methods will produce premium concentrates with easy separation of the economic minerals.

Blue Moon CEO Patrick McGrath, who has 20 years of experience in financing and executive roles in the junior mining public sector, is joined by a management team with successful track records in leading and participating in significant mineral discoveries with development-stage mining companies. The Blue Moon team also includes a member who permitted and built the Soledad mine in southern California in 2016 and a member who re-started the Mesquite mine in southern California. Local knowledge and know-how is key. The company also plans to engage a recognized third-party engineering firm to prepare a preliminary economic assessment report, expected for release in the first quarter of 2018, to demonstrate the economic viability of the Blue Moon mineral resources.

For more information, visit the company’s website at www.BlueMoonMining.com

Let us hear your thoughts: Blue Moon Zinc Corp. Message Board

• Nearly 2 million acres of brine-bearing formations acquired to date
• Successfully extracted lithium from oilfield wastewater brine using proprietary process
• Wastewater treatment industry projected to grow into $45 billion market annually by 2025
• Diversified portfolio of lithium, magnesium and silicon assets in North America
• Global lithium-ion battery market projected to reach $93 billion by 2025

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That’s a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it’s being pulled up to the surface. The company’s petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the “white gold” of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral’s cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies.

For more information, visit the company’s website at www.MGXMinerals.com

Let us hear your thoughts: MGX Minerals Inc. Message Board

• Nearly half of consumers in China pay using mobile devices
• Three-quarters of online payments come through mobile accounts
• Moxian’s apps serve consumers and businesses in the O2O market

The current trends in the global market are encouraging to investors, as consumers increasingly use mobile devices to connect with businesses and make purchases. Moxian, Inc. (NASDAQ: MOXC) recently cited data published by Nielson, in its Global Mobile Money Report (http://dtn.fm/KaG5y), indicating that, in China, nearly half of consumers are likely to use a device when paying a bill at a restaurant, store or bar. The ratio is even higher than in the U.S. and Europe. Mobile payments are growing on a global scale. A forecast by Allied Market Research, in its Mobile Payments Market Report, predicts that the global market may surpass $3.3 billion by 2022, expanding at a compound annual growth rate of 33.4 percent from 2016 to 2022 (http://dtn.fm/5o3Su).

The highest growth, according to the report, is expected to be in the Asia-Pacific region. Moxian has been well aware of the cashless trend in China. It serves the online-to-offline (O2O) market with its Moxian User App and Business App. Both of these feature UnionPay’s payment gateway. This integral system works with Moxian’s MO-Coin and MO-Points virtual currency, so consumers can take advantage of rewards features in the latest app versions.

The User App enables customers to earn MO-Coins by playing games, which they can redeem for prizes. This functionality enables merchants to run their marketing campaigns and advertise to their customers. It helps to learn a great deal about consumer behavior, while users can search for local merchants and obtain news and communicate with friends using the app’s media messenger. Moxian’s Multi-Channel Social Commerce Platform further digs into customer data using business intelligence, social media and entertainment.

Featuring a Social Customer Relationship Management Tool, the Moxian Business App is helping serve the regional market by providing merchants with the ability to establish virtual stores on the company’s platform. It supports various methods of promotion. In addition, customized reports are generated to provide business with insights into purchasing and other customer activity.

Businesses can also leverage automated data analytics tools. The app captures data automatically, so retailers can get the most out of the tools available. These include a loyalty tool that helps enhance marketing strategies. Companies can advertise directly through the platform, as well using a variety of media.

China has 1.3 billion residents. A large number of them use smartphones, and three-quarters of all online payments are sent through mobile accounts, according to analyst estimates. Spending through mobile payment platforms in 2016 was 50-times as much as in the U.S. Consumers are increasingly opting to use resources such as the Moxian O2O marketplace rather than cash. MOXC’s social marketing and promotion platforms enable merchants to target mobile users in their advertising and better interact with consumers. Given the increasing popularity of mobile payments, the company’s solutions are expected to help merchants to continue to grow.

For more information, visit the company’s website at www.Moxian.com

• Health conscious consumers favor cannabis oil extracts and edibles over smoking
• Recent survey shows 46% of Canadians would try cannabis-infused products
• Canadian cannabis oil extraction market expected to reach $1.7 billion by 2020

Algae Dynamics Corp (OTC: ADYNF) is uniquely positioned to benefit from the upcoming legalization of recreational marijuana in Canada by mid-2018. The company’s focus on developing proprietary research and products involving botanical oils derived from cannabis combines two important consumer demands – the well-known health benefits of cannabinoids and a smoke-free alternative to cannabis consumption.

Nearly half of Canadians (46%) polled in August 2017 by Dalhousie University researchers in Nova Scotia (http://dtn.fm/82V9p) said they are interested in trying edible marijuana once recreational marijuana is legalized within the country. To clarify, medical marijuana has been legal in Canada since 2001, with some provisions, and the new law will only allow consumers to purchase dried marijuana and cannabis oil.

The preliminary study, entitled “Cannabis-infused food and Canadian consumers’ willingness to consider marijuana as a food ingredient,” was led by Dr. Sylvain Charlebois, a professor in food distribution and policy on the Faculty of Management at Dalhousie University. Among the findings, the survey shows that the majority of the 1,087 Canadians (68%) surveyed are supportive of legalizing marijuana, and cannabis-infused baked goods, cannabis oils and spices are high on the list of things to try (http://dtn.fm/M9lHB).

Algae Dynamics and its marketing team are actively preparing to respond to an increased market demand once legalization takes place. The company cites a 2016 Mackie Research Capital Corp. estimate involving trends in Colorado, one of the first U.S. states to legalize marijuana, which found that 45% of dried marijuana users would eventually convert to marijuana extracts and/or oils. Algae Dynamics’ strategy includes extracting oils from cannabis and hemp to formulate unique health and nutraceutical products, along with the distinction of becoming a leading medical cannabis producer through its association with two of Canada’s leading research universities – the University of Waterloo and the University of Western Ontario. This collaborative research is focused on the use of extracts from cannabis oil in the context of various forms of cancer, in addition to development of new pharmacotherapies for mental health.

Algae Dynamics has also signed a letter of intent with a licensed cannabis producer that has the capability to grow multiple strains of the highly regulated plant in a state-of-the-art facility. This agreement with 6779264 Manitoba Ltd., dba Bonify, gives Algae Dynamics an improved pathway to early revenues as well as a high-quality source of cannabis oil to support the research already underway at the universities.

Cannabis oils are increasingly being seen by consumers as a much healthier avenue when it comes to cannabis consumption. The Canadian government has stated its intent to delay legalization of edibles past the planned July 1, 2018, deadline (http://dtn.fm/pVj8Z). Instead, the government indicates that it will focus on making products like fresh or dried cannabis, cannabis oils, seeds and plants available for legal purchase.

The underserved market for licensed cannabis producers in Canada, which currently has only 59 licensed producers to serve the country’s population of 35 million, offers great potential for Algae Dynamics. As part of its strategy to be the number one Canadian cannabis research-driven product formulator, Algae Dynamics relies on a formidable leadership team of scientific and strategic advisors that complement the company’s ongoing research and development relationships and initiatives.

For more information, visit the company’s website at www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

• Product portfolio to include drugs and supplements
• Faster monetization of lead Alzheimer’s candidate as supplement
• Market valuation poised to soar

It should come as no surprise to discover that the medical cannabis dispensary product line in America is getting increasingly diverse and sophisticated. After all, the cannabis sativa plant incorporates over 400 chemical entities, of which more than 60 are cannabinoids. Even though cannabis has been used and cultivated by mankind for at least 6,000 years, it was only relatively recently, in 1899, that the first cannabinoid, cannabinol (CBN), was identified and isolated. With so much chemistry wrapped in its trichomes, colas and bracts, the range of ailments for which the plant promises palliatives continues to grow. Based on compelling data, India Globalization Capital, Inc. (NYSE MKT: IGC) was recently able to announce advances in the treatment of Alzheimer’s disease with THC. These encouraging results have brightened the company’s future, since the market for Alzheimer’s therapies is a billion-dollar one.

The IGC press release (http://dtn.fm/Va8MW) provided an update on in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model, showing that, at varying concentrations of THC, the aggregation of Aβ protein decreases by as much as 40%. There are indications that at least one cause of AD may be the buildup of senile plaque composed of amyloid beta peptides (Aβ plaque) in the cerebral cortex and hippocampus. Over time, this plaque destroys neurons and causes synaptic dysfunction, leading to loss of memory.

“These study results, when combined with the earlier reported data that shows IGC-AD1 reduces Aβ40 and Aβ42 production by as much as 50%, and 40%, without any toxicity (http://dtn.fm/b3LDR), represent a highly significant novel breakthrough that could potentially bring much needed relief from this devastating disease,” Ram Mukunda, CEO of IGC, stated in a news release.

IGC stands to benefit in two ways: first, by taking IGC-ADI down the regular FDA route as both a prophylactic and a therapeutic; and second, as a food supplement to be sold in medical dispensaries. The FDA approach to a product labeled as a “drug” is different to one classified as a “supplement”. A drug is considered unsafe until proven otherwise by clinical trials, while a supplement, defined by the Dietary Supplement Health and Education Act (DSHEA) as food, is considered to be prima facie safe. This binal approach allows IGC to secure market share in the medical dispensary segment while IGC-AD1, named Hyalolex, works its way through the FDA approval process.

As IGC’s product initiatives come closer to market, the company is likely to attract increased attention that hoists its valuation in line with peers. Anavex Life Sciences (NASDAQ: AVXL), which recently completed a phase 2a trial of its lead product candidate in patients with mild to moderate Alzheimer’s disease, has a market cap of about $180 million. Its stock has traded between $2.60 and $6.31 over the past year. Shares of Axovant Sciences (NYSE: AXON), currently awaiting the results of a phase III trial for its lead Alzheimer’s candidate, have traded between $11.15 and $24.94 over the past year. The company’s current market cap is over $2.5 billion.

Also, AC Immune Ltd. (NASDAQ: ACIU), which is collaborating with Genentech/Roche, has its Alzheimer’s candidate in phase III. AC Immune’s stock has ranged from $6.70 to $19.30 over the past 12 months. The company is valued at around $381 million. Last but certainly not least is Biogen Inc. (NASDAQ: BIIB), recently added to Goldman Sachs’ (NYSE: GS) Equity Conviction List, which is valued at close to $61 billion. Its stock has traded between $246.00 and $329.00 this past year. Meanwhile, IGC stock currently trades around $0.36, and the company’s market cap is about $12.5 million.

For more information, visit the company’s website at www.IGCInc.us

• In July 2017, POTN had a 30% jump in sales to nearly $1.5 million versus June 2017
• Research report estimates $8.4 million revenues in FY2017, notes POTN plans for international expansion with initial focus on China
• Aggressive marketing strategy and branding means more POTN sales and retail placement from increased exposure at trade and sporting events

PotNetwork Holding, Inc. (OTC: POTN) revenues are projected to reach greater than $30 million by FY2019, $16.7 million in FY2018 and $8.4 million this fiscal year, according to SeeThruEquity, LLC (http://dtn.fm/kSHT9).

POTN is a holding company for subsidiary First Capital Venture Co., which owns Diamond CBD, Inc. Diamond CBD focuses on research and development and multi-national marketing of premium hemp extracts that contain a wide range of cannabinoids based on premium hemp-based extracts and other cannabinoids and hemp-based derivatives. Primarily, it is in the smoke/vape shop industry and is an exhibitor of trade shows in that industry. It markets hemp-based cannabinoid (CBD) extracts, edibles, vapes, creams and other products.

Sales for July 2017 reached $1,459,137, a 30% jump from the prior month. The company announced sales of $5,077,625 for the first six months of FY2017 with a net profit of $369,237. SeeThruEquity has set a price target of $0.25 for the POTN stock and in its report projected that the company will attain a net income of $2.7 million in FY2019.

The report noted that POTN achieved a gain of 178% in year-over-year revenues in 1Q2017. It projects sales of $8.4 million in FY2017. It also acknowledged the company’s aggressive approach to marketing and planned entry into new markets, such as China.

POTN is making its presence felt at high profile industry trade shows. The company has announced its sales of some $820,000 at three such shows in just the past two months: the BIG Industry Trade Show, CHAMPS and Market Week Event. The company has also sought to raise its exposure sponsoring two contenders at the high profile Floyd Mayweather vs. Conor McGregor fight in Las Vegas. SeeThruEquity sees POTN’s publicity efforts as gaining sales traction, brand recognition and retail placement.

It is also eyeing international expansion. The report said that POTN is anticipating entering China with a partner. Additionally, the company is looking at CBD markets in South America including Peru, Bolivia, Ecuador and Chile, the report said.

It is estimated that by 2020, the hemp-based CBD’s product market will reach $1.8 billion, according to Hemp Business Journal (http://dtn.fm/s5NjH). POTN’s line includes Gummy Bears, Sour Bears, Gummy Rings, Rainbow Bites and Choco Peanut Butter, among others.

For more information, visit the company’s website at www.PotNetworkHolding.com

Let us hear your thoughts: PotNetwork Holding, Inc. Message Board

• AppSwarm helps build, market and sell applications through mergers and acquisitions, joint ventures, partnerships and various other agreements
• The company is aiming for $6-7 million in revenue by FY 2018, tapping into the nearly $100 billion global games market
• The app market hit $1.3 trillion in 2016, and AppSwarm’s agreements with major app stores can help developers get to market sooner

In 2016, the global games market generated nearly $100 billion in revenue. AppSwarm, Inc. (OTC: SWRM) has built a business model that enables it to work with application developers and entrepreneurs who are great at creating ideas, but need a helping hand with marketing their products. AppSwarm has the financial resources to assist small application development firms and young entrepreneurs. It employs many strategies, depending on the individual business relationship. The firm has grown through acquisitions and by entering joint ventures and partnerships, royalty agreements and stock purchase agreements.

The company recently announced that it is striving for $6-7 million in revenue by FY2018 (http://dtn.fm/7HDlc). A strong presence in the business, e-commerce, and general games market can help it get there. AppSwarm has structured its model to cater to historically profitable software developers that show growth potential. Merging with such companies, even small developers, gives them the needed financial resources, marketing tools and business management assistance to further their products.

A unique business model is centered on what the company calls the “Swarm.” This process focuses on engagement and retention, the performance of target applications and developers, and a monetization model. Four key revenue streams are implemented. The company is strongly involved in completing the concept and development phase and conducting all necessary functions to get the product on the market. It provides direct sales services as well. Together, these service offerings allow for the incubation of apps from ideation to sale to the end user.

AppSwarm is also active in social game development, both internally and through redeveloping existing apps. Other revenue streams include casino and movie-themed role-playing applications, but the company has also profited by partnering with many different entities, offering financial, operations and marketing resources and expertise. Providing cost-efficient processes to its partners and clients has made SWRM a viable choice for developers looking to give their products a boost.

The app market reached $1.3 trillion in 2016, according to App Annie. Expected to grow substantially over the next few years, the app market is extremely volatile and includes almost every product and service sector. Purchases such as Urban Bamboo Designs, a business serving environmentally conscious consumers looking for quality, stylish products, and VR World, a maker of virtual reality and augmented reality applications, have enabled SWRM to tap into lucrative revenue streams. It has even entered the business applications segment, thanks to a PDF document scanner that works with iPhones and iPads.

An ability to expedite development, financing, creation, and marketing and sales is allowing the company to tap into the large and growing global app market. Agreements with major app stores are in place. AppSwarm can therefore fast track applications so developers can launch their software, satisfy demand in key niches and turn a profit without extended wait periods. The agreements SWRM is capable of managing are enabling it to rapidly increase its presence in the global market.

For more information, visit the company’s website at www.App-Swarm.com

Let us hear your thoughts: AppSwarm, Inc. Message Board

• Leading the way was InfuSystem Holdings (NYSE MKT: INFU), which grew 23%
• Russell 2000 Index increased 1.3%, faster than other major indices
• Second week in a row Bowser Stocks surged higher

Bowser small cap stocks grew 2.6% for the week ended September 22, outperforming major indices, according to The Bowser Report Weekly. InfuSystem Holdings (NYSE MKT: INFU) led the way, growing 23% for the week. Ironically, INFU was the single biggest loser the prior week, with The Bowser Report Weekly attributing that selloff to an increase in volatility. The company provides infusion pumps and related services to medical facilities.

It was the second week in a row that Bowser Stocks showed growth. The Russell 2000 index grew at a 1.3% rate, outperforming the major indices. The Dow Jones Industrial Average (DJIA) grew just 0.4%, and the S&P 500 was up only 0.1%. The report said that smaller stocks are exhibiting relative strength for the one-month period. It expects, though, a loss of growth momentum at a historical supply zone.

The second biggest gainer was Nova Lifestyle (NASDAQ: NVFY), which showed 18% growth. That stock is now up 54% from its 52-week low. The company earlier announced in a press release that it was receiving an award and also expecting growth in the fourth quarter, driven by new product launches and an increase in consumer demand. It is a California-based consumer furniture manufacturer.

For the week, 32 Bowser stocks showed growth and only 11 were in the red. The report added that gold experienced a sharp pullback for the week due to the strength of the U.S. dollar. The report attributed that to a Federal Reserve decision to leave interest rates unchanged.

For more information, refer to The Bowser Report Weekly

• Clinical studies of TurboCBD™ a topic of discussion at Canadian Securities Exchange-sponsored “Cannabis in the Capital Markets” event
• Patents cover variety of lipophilic bio-actives, including cannabinoids, nicotine and vitamins
• Growing portfolio of intellectual property includes 19 patents filed across 44 countries

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), through its proprietary technology for delivering bioactive compounds in lipid formulations, offers licensed partners the ability to include cannabidiol (CBD) in a variety of ingestible products appropriate for medical patients and recreational users alike. In a new report, Grand View Research, Inc., states that the global market for medical cannabis alone is expected to reach a stunning $55.8 billion by 2025 (http://dtn.fm/RfL4n). An increasing interest in the therapeutic value of cannabinoids, especially those delivered in products that can be ingested and not smoked, is one of the main forces driving the market forward, per the report.

Lexaria’s pioneering TurboCBD ™ product presents a revolutionary way to enhance absorption of the benefits CBD provides without having to endure the often unpleasant flavors associated with cannabis compounds. Lexaria’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, with patents pending for THC (tetrahydrocannabinol) and other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and additional molecules.

Dr. Philip Ainsle of the University of British Columbia (UBC) is the principal investigator of Lexaria’s first clinical study of the high-absorption properties of TurboCBD™. The study will evaluate the effects of TurboCBD™ on the cognitive function and cardiovascular health of human volunteers. Dr. Ainsle, co-director of the Centre for Heart, Lung and Vascular Health at the UBC Okanagan Campus in Kelowna, Canada, presented a project update at the Canadian Securities Exchange-sponsored “Cannabis in the Capital Markets” event on September 27 (http://dtn.fm/GV8iN). Lexaria representatives are also scheduled to speak in October at the Southwest Cannabis Conference and Expo in Phoenix, Arizona.

As a business-to-business enterprise, Lexaria’s reach extends to companies located in Canada, several large market states in the U.S., and internationally. An 18-month co-funded research project is underway with Canada’s National Research Council to investigate opportunities associated with bioavailability enhancement of lipophilic active agents – including those within cannabinoids, vitamins, NSAIDs and nicotine. Results from this study could provide Lexaria with a chemical or physical “fingerprint” that could help to identify Lexaria’s technology at work in consumer products.

Lexaria’s technology is capable of helping companies lower costs while providing the best consumer benefit possible. Several third-party partners have signed deals, letters of intent or memorandums of understanding to utilize Lexaria’s proprietary technology for both THC and CBD products where allowed by law. Lexaria and its partners are targeting markets in Canada, the U.S., Japan, South Korea, Mexico and more. Lexaria’s royalty revenue model includes a range of between five and 10 percent of gross sales.

As a bioscience technology disruptor for edible cannabinoids, Lexaria has several branded CBD products available, including protein energy bars, CBD tablets that contain zero sugar, premium teas and TurboCBD ™ in a high absorption, full spectrum hemp oil capsule. Led by CEO Chris Bunka, Lexaria’s management team includes professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skill sets.

For more information, visit the company’s website at www.LexariaEnergy.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board